follow news friday expect
receiv complet respons letter fda gener
proair file longer expect approv
proair gener event lower forecast
news follow prgo result new ep
estim vs previou estim previous
publish report follow result note
overal good quarter opinion
follow result reiter adjust ep
guidanc howev follow proair news
indic delay would neg ep impact
take new assum guidanc rang
updat ep estim lower end new rang
updat price target reflect lower estim
slightli lower termin multipl vs due slower growth
addit model chang includ follow forecast total
revenu billion vs previou billion
forecast rx revenu forecast million vs
forecast billion line previou billion
forecast forecast consum healthcar intern chci
revenu billion line compani guidanc
overal proair news disappoint said note
friday take-away one risk
investor highlight take away risk back-end
load year leav share somewhat less depend
major catalyst albeit without benefit big launch
still think result good line modest growth
pictur manag laid
maintain market perform rate share price
target
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
report non-gaap adjust ep exclud one-tim item
compani prioriti stock list
compani data secur llc estim reuter
previou new incom hc hc adjust ebitda expens expens incom per perrigo compani plc
price target
price target base dcf valuat includ discount rate termin
multipl integr larg part outlook carri substanti risk
risk includ turnaround brand consum healthcar busi weak rx
believ share perform market evid emerg recent
turnaround durabl particularli relat eu busi gener busi
recent under-perform
began packag gener home remedi year later one top
over-the-count over-the-counter consum good product compani market share privat label
store brand also among lead compani pharmaceut gener market
well activ pharmaceut ingredi api market
